This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Atreca Croissance future
Future contrôle des critères 0/6
Atreca is forecast to grow earnings at 4.3% per annum.
Informations clés
4.3%
Taux de croissance des bénéfices
n/a
Taux de croissance du BPA
| Biotechs croissance des bénéfices | 35.6% |
| Taux de croissance des recettes | n/a |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 31 May 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2026 | N/A | -52 | N/A | N/A | 1 |
| 12/31/2025 | N/A | -48 | N/A | N/A | 1 |
| 12/31/2024 | N/A | -38 | N/A | N/A | 1 |
| 12/31/2023 | N/A | -65 | N/A | N/A | 1 |
| 9/30/2023 | N/A | -98 | -65 | -65 | N/A |
| 6/30/2023 | N/A | -85 | -65 | -64 | N/A |
| 3/31/2023 | N/A | -93 | -71 | -70 | N/A |
| 12/31/2022 | N/A | -97 | -82 | -81 | N/A |
| 9/30/2022 | N/A | -105 | -86 | -81 | N/A |
| 6/30/2022 | N/A | -110 | -88 | -81 | N/A |
| 3/31/2022 | N/A | -108 | -93 | -69 | N/A |
| 12/31/2021 | N/A | -109 | -96 | -61 | N/A |
| 9/30/2021 | N/A | -103 | -96 | -63 | N/A |
| 6/30/2021 | N/A | -98 | -93 | -62 | N/A |
| 3/31/2021 | N/A | -92 | -82 | -66 | N/A |
| 12/31/2020 | N/A | -86 | -72 | -67 | N/A |
| 9/30/2020 | N/A | -83 | -70 | -65 | N/A |
| 6/30/2020 | N/A | -76 | -71 | -65 | N/A |
| 3/31/2020 | N/A | -74 | -67 | -63 | N/A |
| 12/31/2019 | N/A | -67 | -62 | -59 | N/A |
| 9/30/2019 | N/A | -59 | -56 | -53 | N/A |
| 6/30/2019 | N/A | -53 | -47 | -45 | N/A |
| 3/31/2019 | N/A | -44 | -41 | -40 | N/A |
| 12/31/2018 | N/A | -38 | -36 | -35 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: 0C1 is forecast to remain unprofitable over the next 3 years.
Bénéfices vs marché: 0C1 is forecast to remain unprofitable over the next 3 years.
Croissance élevée des bénéfices: 0C1 is forecast to remain unprofitable over the next 3 years.
Chiffre d'affaires vs marché: Insufficient data to determine if 0C1's revenue is forecast to grow faster than the German market.
Croissance élevée des revenus: 0C1 is forecast to have no revenue next year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if 0C1's Return on Equity is forecast to be high in 3 years time